BioVaxys Technology Corp. (BIOV)の価格はいくらですか

BioVaxys Technology Corp. (BIOV)の価格は$0.05137558です

BioVaxys Technology Corp. (BIOV)の時価総額は何ですか

BioVaxys Technology Corp. (BIOV)の時価総額は$1.50Mです

BioVaxys Technology Corp.（BIOV）の株価履歴

BioVaxys Technology Corp. is a clinical-stage biotechnology company specializing in the development of vaccine platforms designed to combat both viral infections and cancer. The company's pipeline includes BVX-0320, a single-strain vaccine for SARS-CoV-2, and BVX-0918A, an experimental haptenized tumor cell vaccine targeting ovarian cancer. Additionally, BioVaxys offers CoviDTH, an immunodiagnostic tool to detect immune system activity in SARS-CoV-2-exposed patients. Further initiatives encompass Papilocare, aimed at HPV-dependent cervical lesions, along with BVX-0918C for cervical cancer, the HPV viral vaccine BVX-0204, and BVX-0121, a multivalent SARS-CoV-2 vaccine. BioVaxys has established strategic collaborations, such as a bioproduction agreement with WuXi Biologics Limited to manufacture SARS-CoV-2 s-proteins crucial for BVX-0320 and CoviDTH. It also holds a research partnership with The Ohio State University, Wexner School of Medicine, focusing on BVX-0320, and has engaged Bioanalytical Systems, Inc. for preclinical toxicology evaluations of its CoviDTH immunodiagnostic. The company is headquartered in Vancouver, Canada.

年	パフォーマンス
2026 (TTM)	-17.58%
2025	-62.92%
2024	170.02%
2023	-84.82%
2022	-43.00%
2021	-5.87%
2020	507.75%
2019	-27.50%
2018	0.00%

年

パフォーマンス

2026 (TTM)

-17.58%

2025

-62.92%

2024

170.02%

2023

-84.82%

2022

-43.00%

2021

-5.87%

2020

507.75%

2019

-27.50%

2018

0.00%

企業	株価	変化率 1年%	国
Vertex Pharmaceuticals Incorporated VRTX.US	$505.24	28.63%	US
Argenx SE ARGX.US	$846.09	29.41%	NL
Lonza Group AG LONN.SW	$731.69	6.47%	CH
Samsung Biologics Co.,Ltd. 207940.KS	$1.07K	-6.40%	KR
UCB S.A. UCB.BR	$251.82	11.75%	BE

企業

株価

変化率 1年%

国